By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation and analyze site usage.
Computable drug discovery

Developing the Algorithms to Automate Drug Discovery

Our mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning.
Computable drug discovery

Developing the Algorithms to Automate Drug Discovery

Our mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning.
Computable drug discovery

Developing the Algorithms to Automate Drug Discovery

Our mission is to accelerate the transition to rational, computerized drug discovery via simulations and machine learning.
MacBook mockup
Some of Our Partners
mission

Accelerate the transition to rational, computerized drug discovery

In order to fulfill our vision, we work with our customers by becoming key technology partners, boosting their discovery workflow with the most innovative solutions.

Science, research, innovation, and development are the founding pillars of our company.

Acellera at a glance

8,974
Papers citing Acellera's founders
832
Papers citing ACEMD software
16
Years of know-how in computational drug discovery

Acellera at a glance

Today, our software ACEMD has over 700 citations, and KDeep and Deepsite are among the most cited papers in the field of ML applied to drug discovery.
8,974
Papers citing Acellera's founders
832
Papers citing ACEMD software
16
Years of know-how in computational drug discovery
Learn More
Let's work together

Why Acellera

By partnering with Acellera, companies can leverage our innovative technology to transform drug discovery, reduce costs, and ultimately bring life-saving medications to market faster.

CRO

Deliverable-based work orders
Using compute and Acellera’s technology
Focused on a specific problem for a few months

Preclinical partnerships

From target to investigational new drug (IND) applications
FTE, milestone payments and royalties
Experimental validation

Platform development

Co-development and validation of key technologies
OpenScience, co-licensed
FTE for at least one year
Our platform

Accelerating innovation

Cutting-edge algorithms and machine learning techniques streamline and expedite the drug discovery process. Acellera's expertise in GPU-accelerated molecular dynamics and deep learning platforms enables more accurate and efficient drug design.

ACEMD platform

A software framework for molecular dynamics-based discovery. It's the most advanced molecular dynamics ecosystem for molecular simulations.

PlayMolecule molecular discovery platform

PlayMolecule is our computer aided drug discovery. PlayMolecule is a virtual environment for computable drug discovery where algorithms, data and computers are integrated to discover new knowledge.
Acellera platform preview

Find out how we can help.

Let's Talk
support team membersupport team officesupport team ladycustomer support teamprofessional support team